Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1979 1
1985 1
1987 1
1988 2
1989 3
1990 4
1991 4
1992 5
1993 6
1994 6
1995 3
1996 3
1997 6
1998 2
2000 4
2001 3
2002 4
2003 5
2004 6
2005 3
2006 5
2007 9
2008 6
2009 8
2010 13
2011 6
2012 7
2013 6
2014 13
2015 13
2016 9
2017 4
2018 11
2019 21
2020 25
2021 30
2022 38
2023 43
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Infiltrating bladder urothelial carcinoma"
Page 1
Single-cell atlases link macrophages and CD8(+) T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma.
Liang Y, Tan Y, Guan B, Guo B, Xia M, Li J, Shi Y, Yu Z, Zhang Q, Liu D, Yang X, Hao J, Gong Y, Shakeel M, Zhou L, Ci W, Li X. Liang Y, et al. Theranostics. 2022 Nov 14;12(18):7745-7759. doi: 10.7150/thno.77281. eCollection 2022. Theranostics. 2022. PMID: 36451860 Free PMC article.
Rationale: Immune checkpoint inhibitors (ICIs) have revolutionized the management of locally advanced or metastatic urothelial carcinoma. Strikingly, compared to urothelial carcinoma of the bladder (UCB), upper tract urothelial carcino …
Rationale: Immune checkpoint inhibitors (ICIs) have revolutionized the management of locally advanced or metastatic urothelial car …
MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q, Zhang S, Zhang H, Sun J, Lu J, Wang G, Wang X. Dong Q, et al. Int Immunopharmacol. 2023 Mar;116:109783. doi: 10.1016/j.intimp.2023.109783. Epub 2023 Feb 9. Int Immunopharmacol. 2023. PMID: 36773567
RESULTS: In general, MARCO had a substantial impact on the prognosis of cancer patients and was expressed differently in cancer and adjacent normal tissues. High expression of MARCO was associated with poorer OS in bladder urothelial carcinoma (BLCA), breast …
RESULTS: In general, MARCO had a substantial impact on the prognosis of cancer patients and was expressed differently in cancer and adjacent …
Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X, Wang Y, A G, Qu C, Chen J. Zhang X, et al. Front Immunol. 2021 Aug 31;12:721030. doi: 10.3389/fimmu.2021.721030. eCollection 2021. Front Immunol. 2021. PMID: 34531868 Free PMC article.
Further, high PARP1 expression was significantly associated with six immune cells (B cells, CD4+ T cells, CD8+ T cells, macrophages, neutrophils, and dendritic cells) in most tumors, including colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC) …
Further, high PARP1 expression was significantly associated with six immune cells (B cells, CD4+ T cells, CD8+ T cells, macrophages, neutrop …
A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors.
Cui X, Zhang X, Liu M, Zhao C, Zhang N, Ren Y, Su C, Zhang W, Sun X, He J, Gao X, Yang J. Cui X, et al. Genomics. 2020 Nov;112(6):3958-3967. doi: 10.1016/j.ygeno.2020.06.044. Epub 2020 Jul 6. Genomics. 2020. PMID: 32645525 Free article.
Although emerging cell- or animal-based evidence supports the relationship between SND1 and cancers, no pan-cancer analysis is available. ...SND1 expression was associated with the CD8(+)T-cell infiltration level in colon adenocarcinoma and melanoma, and canc …
Although emerging cell- or animal-based evidence supports the relationship between SND1 and cancers, no pan-cancer analysis is availa …
A novel cuproptosis pattern and tumor immune microenvironment characterization in urothelial carcinoma of the bladder.
Feng H, Deng Z, Huang Y, Liu Z, Ruan Y, Wang T, Liu J. Feng H, et al. Front Immunol. 2023 Aug 17;14:1219209. doi: 10.3389/fimmu.2023.1219209. eCollection 2023. Front Immunol. 2023. PMID: 37662947 Free PMC article.
BACKGROUND: Urothelial carcinoma of the bladder (UCB) is the most prevalent malignant tumor of the urinary system worldwide, which has a significant recurrence rate despite multiple treatment options available. ...Finally, the capacity of scoring …
BACKGROUND: Urothelial carcinoma of the bladder (UCB) is the most prevalent malignant tumor of the urinary syste …
Young population bladder neoplasms.
Çivi Çetin K, Öner S, Erdoğan B, Simşek G, Sezer M. Çivi Çetin K, et al. Eur Rev Med Pharmacol Sci. 2023 Nov;27(21):10454-10461. doi: 10.26355/eurrev_202311_34320. Eur Rev Med Pharmacol Sci. 2023. PMID: 37975369 Free article.
OBJECTIVE: Bladder urothelial carcinoma is a rare condition that primarily affects the elderly and is rare in people under 40 years of age. ...The age ranged between 19 and 40, and the average was 30.6. One infiltrating urothelial carcinoma …
OBJECTIVE: Bladder urothelial carcinoma is a rare condition that primarily affects the elderly and is rare in people un …
Receptor Tyrosine Kinase Pathway and Infiltrating Urothelial Carcinoma.
Buyucek S, Coskun SK, Onal B, Gamsizkan M, Cangur S, Esbah O. Buyucek S, et al. J Environ Pathol Toxicol Oncol. 2023;42(1):65-77. doi: 10.1615/JEnvironPatholToxicolOncol.2022044380. J Environ Pathol Toxicol Oncol. 2023. PMID: 36734953
Receptor tyrosine kinase pathway is frequently searched for cancer causing mutations in tumors. Emerging targeted therapies are gleam of hope for them. Infiltrating urothelial carcinoma can have many morphological aspects according to their differentiation/va …
Receptor tyrosine kinase pathway is frequently searched for cancer causing mutations in tumors. Emerging targeted therapies are gleam of hop …
Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Wang X, Bai Y, Zhang F, Li D, Chen K, Wu R, Tang Y, Wei X, Han P. Wang X, et al. Front Immunol. 2023 Mar 17;14:955949. doi: 10.3389/fimmu.2023.955949. eCollection 2023. Front Immunol. 2023. PMID: 37006317 Free PMC article.
The most commonly mutated genes of BLCA were different between high and low COL10A1 groups. Tumor immune infiltrating analyses showed that COL10A1 might have an essential role in recruiting infiltrating immune cells and regulating immunity in BLCA, thus affecting pr …
The most commonly mutated genes of BLCA were different between high and low COL10A1 groups. Tumor immune infiltrating analyses showed …
APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S, Li Y, Xu J, Shen L. Zhao S, et al. Neurol Res. 2024 Mar;46(3):227-242. doi: 10.1080/01616412.2023.2287340. Epub 2024 Jan 22. Neurol Res. 2024. PMID: 38007705
A3C and the A3C score were also correlated with immune cell infiltration and the expression of immune checkpoints. ...Developing drugs to block A3C could enhance the efficiency of immunotherapy and improve disease survival.Abbreviation: A3C: Apolipoprotein B …
A3C and the A3C score were also correlated with immune cell infiltration and the expression of immune checkpoints. ...D …
Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survival.
Woo S, Ghafoor S, Das JP, Gangai N, Goh AC, Vargas HA. Woo S, et al. Urol Oncol. 2022 Mar;40(3):108.e1-108.e10. doi: 10.1016/j.urolonc.2021.09.017. Epub 2021 Nov 5. Urol Oncol. 2022. PMID: 34750054 Free PMC article.
OBJECTIVES: Plasmacytoid urothelial carcinomas (PUC) of the bladder are rare variants known for diffuse and infiltrative spread, however their magnetic resonance imaging (MRI) features are not well established. We aimed to evaluate MRI features of PUC of the …
OBJECTIVES: Plasmacytoid urothelial carcinomas (PUC) of the bladder are rare variants known for diffuse and infiltrative …
314 results